Articles by Disease (Colorectal Cancers)

Oncolytic Viruses: Programmable Tumour Hunters

Journal: Current Gene Therapy
Volume: 2
Page: 243-254
Author(s): J. C. Bell, K. A. Garson, B. D. Lichty and F. D. Stojdl

Cancer Gene Therapy with Tissue Inhibitors of Metalloproteinases (TIMPs)

Journal: Current Gene Therapy
Volume: 2
Page: 255-271
Author(s): Karsten Brand

Recent Advances in the Chemistry and Biology of Folypoly-γ-glutamate Synthetase Substrates and Inhibitors

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 2
Page: 331-355
Author(s): Aleem Gangjee, Nauzer P. Dubash, Yibin Zeng and John J. McGuire

Drug Resistance and Apoptosis in Cancer Treatment: Development of New Apoptosis-Inducing Agents Active in Drug Resistant Malignancies

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 2
Page: 387-401
Author(s): M. Tolomeo and D. Simoni

Recent Progress in the Development of Anticancer Agents

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 2
Page: 419-439
Author(s): Sandor Eckhardt

Physiology of Folic Acid in Health and Disease

Journal: Current Drug Metabolism
Volume: 3
Page: 211-223
Author(s): O. Stanger

Vinorelbine in the Treatment of Non-Small Cell Lung Cancer

Journal: Current Medicinal Chemistry
Volume: 9
Page: 879-891
Author(s): Cesare Gridelli and Rocco De. Vivo

Subject Index To Volume 1

Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 2
Page: 105-105
Author(s): Science Publishers Bentham and Bentham Science Publishers

Prospects for Anti-Neoplastic Therapies Based on Telomere Biology

Journal: Current Cancer Drug Targets
Volume: 2
Page: 1-17
Author(s): sheila A. Stewart and William C. Hahn

Application of Phage Display Technology to Cancer Research

Journal: Current Pharmaceutical Biotechnology
Volume: 3
Page: 29-43
Author(s): Yum L. Yip and Robyn L. Ward